AFP and hepatocellular carcinoma: A meta-analysis has shown that AFP-L3 has high specificity but low sensitivity for the diagnosis of early-stage HCC, suggesting that AFP-L3 is more valuable for ruling out HCC in conditions with elevated AFP levels than for diagnosing early HCC (24).